Friday, January 13, 2017

Australian Drug Maker Has Low Profile but Powerful Backers in Washington


By KATIE THOMAS from NYT Health Australian Drug Maker Has Low Profile but Powerful Backers in Washington
Representatives Chris Collins and Tom Price and other power players have substantial investments in Innate Immunotherapeutics, a company with no approved drugs. Read more article at hafana

No comments:

Post a Comment